XERS supply chain intelligence for Xeris Biopharma Holdings, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Xeris Biopharma Holdings, Inc. (XERS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CORT | Corcept Therapeutics Incorporated | 72% | Reciprocal relationship from CORT graph: range of disorders, including central serous retinopathy, post-traumatic stress disorder, anxiety, alcoholism, cocaine addiction, Alzheimer’s disease, ALS, hy… |
| CORT | Corcept Therapeutics Incorporated | 72% | duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device sub-assemblies at its facility in Taiwan… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from XERS graph: completion of extensive preclinical laboratory tests, animal studies and formulation studies in accordance with appl… |
| ORANY | ORANY | 72% | completion of extensive preclinical laboratory tests, animal studies and formulation studies in accordance with applicable regulations, including the FDA’s Good Laboratory Practice ("GLP") regulation… |
| TEVJF | Teva Pharmaceutical Industries Limited | 72% | Reciprocal relationship from TEVJF graph: Reciprocal relationship from XERS graph: Reciprocal relationship from TEVJF graph: Reciprocal relationship from XERS graph: duct in Gvoke HypoPen is a propri… |
| TEVJF | Teva Pharmaceutical Industries Limited | 72% | duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device sub-assemblies at its facility in Taiwan… |
| BBNX | Beta Bionics, Inc. | 62% | Reciprocal relationship from BBNX graph: Reciprocal relationship from XERS graph: Reciprocal relationship from BBNX graph: Reciprocal relationship from XERS graph: Reciprocal relationship from BBNX g… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CORT | Corcept Therapeutics Incorporated | 72% | Reciprocal relationship from CORT graph: ol synthesis inhibitor osilodrostat to treat patients with Cushing’s disease, which approval was broadened in April 2025 to include adult patients with any et… |
| CORT | Corcept Therapeutics Incorporated | 72% | duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device sub-assemblies at its facility in Taiwan… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from XERS graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from XERS graph: duct in Gvoke HypoPen is a propri… |
| ORANY | ORANY | 72% | duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device sub-assemblies at its facility in Taiwan… |
| TEVJF | Teva Pharmaceutical Industries Limited | 72% | duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device sub-assemblies at its facility in Taiwan… |
| TEVJF | Teva Pharmaceutical Industries Limited | 72% | Reciprocal relationship from TEVJF graph: Reciprocal relationship from XERS graph: duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC… |
| SOMERSET-THERAPEUTICS-LLC | SOMERSET-THERAPEUTICS-LLC | 62% | hree months ended March 31, 2026 and 2025 as well as factors that impact those items. Product revenue, net Product revenue, net, represents gross product sales less estimated allowances for patient c… |
| STRONGBRIDGE-DUBLIN-LIMITED | STRONGBRIDGE-DUBLIN-LIMITED | 62% | hree months ended March 31, 2026 and 2025 as well as factors that impact those items. Product revenue, net Product revenue, net, represents gross product sales less estimated allowances for patient c… |
| TARO-PHARMACEUTICALS-NORTH-AMERICA-INC | TARO-PHARMACEUTICALS-NORTH-AMERICA-INC | 62% | vements are limited by the expected lease term, which includes renewal options reasonably certain to be exercised. The majority of the Company's real estate leases require that the Company pay mainte… |
| TORRENT-PHARMACEUTICALS-LIMITED | TORRENT-PHARMACEUTICALS-LIMITED | 62% | hree months ended March 31, 2026 and 2025 as well as factors that impact those items. Product revenue, net Product revenue, net, represents gross product sales less estimated allowances for patient c… |
| XERIS-PHARMACEUTICALS-INC | XERIS-PHARMACEUTICALS-INC | 62% | hree months ended March 31, 2026 and 2025 as well as factors that impact those items. Product revenue, net Product revenue, net, represents gross product sales less estimated allowances for patient c… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| XERS-DEBT | Debt stack $252.6M | 90% | Market cache reports total debt of $252.6M. |
| XERS-DEBT-13654 | Warrants outstanding: 2275313 | 90% | xbrl warrant detail from xbrl 2026-01-31. |
| XERS-DEBT-13655 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2025-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| XERS-OWNER-BLACKROCK-INC | BlackRock, Inc. | 90% | 13F overlay lists BlackRock, Inc. as top holder; 240 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| TEVJF | Teva Pharmaceutical Industries Limited | 100.00 | 1 | ['customer', 'supplier'] |
| ORANY | ORANGE | 100.00 | 1 | ['customer', 'supplier'] |
| BBNX | Beta Bionics, Inc. | 100.00 | 1 | ['supplier'] |
| AMZE | Amaze Holdings, Inc. | 50.00 | 2 | |
| CYCN | Cyclerion Therapeutics, Inc. | 50.00 | 2 | |
| D | Dominion Energy, Inc. | 50.00 | 2 | |
| AYTU | Aytu BioPharma, Inc. | 50.00 | 2 | |
| CANF | Can-Fite BioPharma Ltd. | 50.00 | 2 | |
| DFTX | Definium Therapeutics, Inc. | 50.00 | 2 | |
| CHUC | Charlie's Holdings, Inc. | 50.00 | 2 | |
| CLNE | Clean Energy Fuels Corp. | 50.00 | 2 | |
| FENC | Fennec Pharmaceuticals Inc. | 50.00 | 2 | |
| EQR | Equity Residential | 50.00 | 2 | |
| ALVO | Alvotech | 50.00 | 2 | |
| CNOB | ConnectOne Bancorp, Inc. | 50.00 | 2 | |
| AZN | AstraZeneca PLC | 50.00 | 2 | |
| DWTX | Dogwood Therapeutics, Inc. | 50.00 | 2 | |
| ESS | Essex Property Trust, Inc. | 50.00 | 2 | |
| ED | Consolidated Edison, Inc. | 50.00 | 2 | |
| DARE | Daré Bioscience, Inc. | 50.00 | 2 |